Amplify Weight Loss Drug & Treatment ETF Rating $23.86 -0.53 (-2.17%) As of 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsShort InterestBuy This Stock Amplify Weight Loss Drug & Treatment ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.THNR Aggregate RatingModerate Buy 2.52Holdings in THNR have an aggregate rating of Moderate Buy based on 204 analyst ratings issued in the past year covering 11 companies (66.3% of the portfolio).THNR Aggregate Price Target$23.86High Prediction$23.86Average Prediction$23.86Low Prediction$23.86Holdings in THNR have an aggregate price target of $23.86 and a range of $23.86 to $23.86 covering 11 companies (66.3% of the portfolio).THNR Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy1 Buy rating(s)Moderate Buy5 Moderate Buy rating(s)Hold4 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Amplify Weight Loss Drug & Treatment ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 11 THNR Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings12.80%NVONovo Nordisk A/S$56.95-3.0%4.3948 of 5 stars2.50$77.50 36.1%20Trending News12.04%LLYEli Lilly and Company$833.08-2.6%4.9921 of 5 stars2.64$948.56 13.9%25Trending NewsAnalyst Forecast6.59%REGNRegeneron Pharmaceuticals$564.63-0.9%4.7035 of 5 stars2.79$817.46 44.8%29Trending NewsAnalyst ForecastAnalyst Revision6.47%AMGNAmgen$290.13-1.8%4.5647 of 5 stars2.35$309.42 6.6%20Positive NewsAnalyst UpgradeAnalyst Revision5.72%HIMSHims & Hers Health$53.98-7.3%3.2965 of 5 stars1.93$38.92 -27.9%14Insider Trade5.08%ABBVAbbVie$230.88+0.1%4.582 of 5 stars2.79$231.90 0.4%28Positive NewsAnalyst Forecast4.81%PFEPfizer$24.81-1.7%4.9584 of 5 stars2.37$28.35 14.3%19Trending NewsDividend AnnouncementAnalyst ForecastOptions Volume4.62%MRKMerck & Co., Inc.$86.02-1.7%4.9935 of 5 stars2.29$104.31 21.3%21Trending NewsAnalyst ForecastAnalyst Revision4.58%AZNAstraZeneca$84.53-0.6%2.9473 of 5 stars2.80$86.00 1.7%5Trending NewsAnalyst ForecastHigh Trading Volume1.96%SRRKScholar Rock$39.46-3.7%4.5261 of 5 stars3.07$47.00 19.1%15Analyst ForecastInsider Trade1.67%MTSRMetsera$52.87+0.5%N/A2.38$55.75 5.4%8Analyst Forecast This page (NYSEARCA:THNR) was last updated on 10/10/2025 by MarketBeat.com Staff From Our PartnersOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredMiss This IRS Strategy Now, Regret It LaterWith Donald Trump back in the White House, many believe an economic revival could be underway — but it also br...American Alternative | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amplify Weight Loss Drug & Treatment ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Amplify Weight Loss Drug & Treatment ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
